Ma and coworkers evaluated the anti-tumor activity of BMSCs pulsed with homologous tumor-derived exosomes (TEX) and IFN-γ and unveiled that this strategy can augment the antitumor activity of MSCs (47). The gene discussed is IFNG; the disease is neoplasm.